{"version":"1.0","type":"link","title":"Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancer.","author_name":"Van Mackelenbergh MT 외","author_url":"https://prs-insight.online/author/Van%20Mackelenbergh%20MT","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/76639","thumbnail_width":1200,"thumbnail_height":630}